🔗 Share this article

Texas Attorney General Ken Paxton is filing a lawsuit against the producers of Tylenol, alleging the corporations hid potential risks that the medication created to children's neurological development.

The lawsuit follows four weeks after Former President Trump advocated an unverified association between taking acetaminophen - referred to as paracetamol - during pregnancy and autism in young ones.

The attorney general is taking legal action against the pharmaceutical giant, which formerly manufactured the drug, the sole analgesic suggested for pregnant women, and the current manufacturer, which currently produces it.

In a declaration, he claimed they "betrayed America by profiting off of pain and marketing drugs regardless of the potential hazards."

The company asserts there is lacking scientific proof tying Tylenol to autism.

"These corporations lied for decades, knowingly endangering millions to increase profits," the attorney general, from the Republican party, said.

The manufacturer stated officially that it was "very worried by the dissemination of inaccurate information on the safety of acetaminophen and the likely effects that could have on the welfare of women and children in America."

On its official site, Kenvue also stated it had "consistently assessed the relevant science and there is lacking reliable evidence that indicates a established connection between taking acetaminophen and autism."

Organizations acting on behalf of medical professionals and healthcare providers agree.

The American College of Obstetricians and Gynecologists has stated acetaminophen - the primary component in acetaminophen - is among limited choices for women during pregnancy to manage pain and elevated temperature, which can present major wellness concerns if not addressed.

"In over twenty years of investigation on the utilization of paracetamol in gestation, not a single reputable study has successfully concluded that the use of paracetamol in any stage of gestation leads to brain development issues in offspring," the association said.

The court filing references recent announcements from the former administration in arguing the medication is allegedly unsafe.

Last month, Trump raised alarms from medical authorities when he advised expectant mothers to "resist strongly" not to take Tylenol when ill.

Federal regulators then released a statement that medical professionals should contemplate reducing the usage of Tylenol, while also mentioning that "a direct connection" between the drug and autism in young ones has not been established.

The Health Department head Kennedy, who manages the Food and Drug Administration, had pledged in April to conduct "comprehensive study program" that would establish the source of autism in a matter of months.

But specialists advised that discovering a single cause of autism - considered by experts to be the outcome of a complex mix of inherited and external influences - would be difficult.

Autism is a form of enduring cognitive variation and disability that affects how individuals perceive and interact with the surroundings, and is recognized using medical professional evaluations.

In his court filing, the attorney general - who supports Trump who is running for US Senate - alleges Kenvue and J&J "intentionally overlooked and sought to suppress the evidence" around paracetamol and autism spectrum disorder.

The lawsuit seeks to make the corporations "eliminate any commercial messaging" that asserts acetaminophen is safe for expectant mothers.

The court case echoes the grievances of a group of parents of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the manufacturers of acetaminophen in two years ago.

The court threw out the case, declaring investigations from the plaintiffs' authorities was not conclusive.